Glycemic Control in Critical Care

a summary

0.5 CPD Points, 0.5 AMA PRA Category 1 Credits, 0.5 CEUs.
Providers: CPDUK, EB Medicine, CBRN

info_outline You can watch this lecture for free. For premium features, including a CPD/CME accredited certificate or to use time-coded note taking, you will need a fair price subscription.

Sign In or Sign Up For Free to access this lecture.

Melissa Villerot help_outline
Assistant Professor of Nursing, Michigan State University, USA
Lecture Summary

537 million adults worldwide are living with diabetes mellitus (DM) and over 3 in 4 reside in low-and middle-income countries (LMICs). Patients, with or without DM, requiring critical care often experience dysglycemia—a combination of hyperglycemia due to illness/injury, hypoglycemia due to decreased oral intake/appetite, nausea/vomiting, as well as glucose variability which leads to increased risk of infection, hospital-acquired foot ulcers, length of stay, and overall mortality. Optimizing glycemic control when blood glucose rises above 180 mg/dL (10 mmol/L) via insulin infusion with a target range of 140-180 mg/dL (7.8-10 mmol/L) is a best practice for most critical care patients. Less than 1 in 10 people with diabetes in LMICs receive comprehensive glycemic control care. Improving the ability of health systems to provide treatment addressing glycemic control, as well as cardiovascular disease risk factors that so often accompany DM, e.g., hypertension and hypertriglyceridemia, are pressing international priorities.

Target Audience

Critical Care Nurses
Advanced Practice Providers
Critical Care Doctors

Learning Objectives:

Upon completion of this activity, you should be able to:

  • Review basic physiology/pathophysiology related to glycemic control
  • Discuss critical care specific interventions for optimizing glycemic control
  • Analyze implications for glycemic control in low- and middle-income countries
Release Date

1 November 2020

Termination Date

31 October 2023

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of EB Medicine and Continulus. EB Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

EB Medicine designates this internet-enduring material for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Needs Assessment

The need for this educational activity was determined by surveys of the target audience and experts in the specialty. Further assessment was provided by examining the topics of recently published evidence-based medicine reviews, national clinical guidelines, and specialty society recommendations, as well as suggestions from evaluations of previous learning programs to determine practice gaps.

CME Faculty Disclosure

It is the policy of EB Medicine to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-sponsored educational activities. All faculty participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. In compliance with all ACCME accreditation requirements and policies, all faculty for this CME activity were asked to complete a full disclosure statement. The speaker did not report any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) discussed in this educational presentation.

Earning Credit

In order to earn CME credit, the participant must take the pre-test, watch the course, take the CME post-test, and complete the post-test evaluation.

Hardware/Software Requirements

Online learners will need a computer or web-enabled device to access the podcast, additional learning materials, and CME test.

Commercial Support

This activity received no commercial support.